Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Copernicus Capital Management, LLC 13F Holdings -- Portfolio & Top Positions (2021-09-30)

Copernicus Capital Management, LLC (CIK 1694620) reported $8.3M across 13 reported positions in its SEC 13F filing for 2021-09-30. Largest positions: PFE ($1.3M, 15.61%), TMO ($1.1M, 13.83%), TDOC ($888,000, 10.75%), BMRN ($850,000, 10.29%), JNJ ($808,000, 9.78%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1PFEPFIZER INC$1.3M15.61%30,000New
2TMOTHERMO FISHER SCIENTIFIC INC$1.1M13.83%2,000New
3TDOCTELADOC HEALTH INC$888,00010.75%7,000New
4BMRNBIOMARIN PHARMACEUTICAL INC$850,00010.29%11,000New
5JNJJOHNSON & JOHNSON$808,0009.78%5,000New
6FATEFATE THERAPEUTICS INC$711,0008.60%12,000Added
7HZNPHORIZON THERAPEUTICS PUB L$657,0007.95%6,000Added
8RCUSARCUS BIOSCIENCES INC$593,0007.18%17,000Trimmed
9ALLOALLOGENE THERAPEUTICS INC$386,0004.67%15,000New
10MDTMEDTRONIC PLC$376,0004.55%3,000New
11PRQRPROQR THRAPEUTICS N V$335,0004.05%40,000New
12IMTXIMMATICS N.V$130,0001.57%10,000New
13FOLDAMICUS THERAPEUTICS INC$96,0001.16%10,000New
14ACCDACCOLADE INC$00.00%0Exited
15ATRAATARA BIOTHERAPEUTICS INC$00.00%0Exited
16GRTSGRITSTONE BIO INC$00.00%0Exited
17TCRRTCR2 THERAPEUTICS INC$00.00%0Exited
18SKINTHE BEAUTY HEALTH COMPANY$00.00%0Exited
19VRTXVERTEX PHARMACEUTICALS INC$00.00%0Exited
20ZNTLZENTALIS PHARMACEUTICALS INC$00.00%0Exited
21JAZZJAZZ PHARMACEUTICALS PLC$00.00%0Exited

Source: SEC Form 13F filings · as of 2021-09-30